Vedolizumab Exposure Levels and Clinical Outcomes in Ulcerative Colitis: Determining the Potential for Dose Optimisation
Alimentary Pharmacology and Therapeutics - United Kingdom
doi 10.1111/apt.15113
Full Text
Open PDFAbstract
Available in full text
Date
January 20, 2019
Authors
Publisher
Wiley